Teri Moser Woo, PhD, RN, ARNP, CNL, CPNP, FAANP


For more than 20 years, Teri Moser Woo has been a devoted member of the National Association of Pediatric Nurse Practitioners (NAPNAP) and has been actively involved as a conference speaker for NAPNAP’s educational sessions and serving as a volunteer representative for the Centers for Disease Control and Prevention and Pew Charitable Trusts “Outpatient Antibiotic Prescribing: Setting a National Goal for Reducing Inappropriate Use” project. She is co-editor of the pharmacology column in the Journal of Pediatric Healthcare. Dr. Woo’s hard work and dedication as a NAPNAP volunteer is inspiring.

We touched base with Dr. Woo, an expert in antibiotic use and resistance, and here are her thoughts on antibiotic prescribing:

Q. What event in your personal or professional experience sparked you to become involved in reducing inappropriate antibiotic prescribing?

A. I have been concerned about inappropriate prescribing because I worry about increasing antibiotic resistance. In my 22 years as a PNP, there are many antibiotics we used to use commonly in pediatrics that cannot be used anymore due to resistance. I see inappropriate prescribing as both over-prescribing and prescribing the wrong antibiotic for the pathogen, as in the case of prescribing azithromycin for acute otitis media and sinusitis.

Q. What makes inappropriate antibiotic prescribing such an important issue for children’s overall, long-term wellness?

A. We place children at risk for C. difficile infections and developing infections resistant to first line antibiotics when we inappropriately prescribe. Every prescriber, including every pediatric-focused APRN is responsible for antibiotic stewardship in their practice.

Q. What are the goals of the CDC and Pew Charitable Trust in their national Outpatient Antibiotic Prescribing program, and how are they planning to achieve them?

A. CDC and Pew are approaching inappropriate antibiotic use from multiple directions, including animal use, inpatient and outpatient use with a goal of reducing antibiotic resistance.

Q. What piece of advice would you offer to other NAPNAP members who would like to put their expertise to work for a government agency at the national, state or local level?

A. Volunteer! I am often the only nurse on an expert panel and we need more nurses, especially PNPs at the table. NPs are becoming a greater portion of providers and it is critical we are involved with policy development and lend our expertise to agencies.

Learn how to update your profile on Team Peds: Volunteer website to make yourself available for future opportunities!

When not volunteering with NAPNAP, Teri Moser Woo has many important roles. Dr. Woo is the associate dean for graduate nursing programs and associate professor at Pacific Lutheran University. She is co-author of “Pharmacotherapeutics for Nurse Practitioner Prescribers,” has written and lectured extensively in the area of pediatric pharmacology and serves on the Pediatric Nursing Certification Board Pharmacology Self-Assessment exam committee. She has served on the National Institute of Child Health and Human Development Annual Best Pharmaceuticals for Children Act Scientific Prioritization committee.